Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

NCT02833948 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin

NCT03673605 ·Status: WITHDRAWN ·Phase: PHASE4

Revacept in Symptomatic Carotid Stenosis

NCT01645306 ·Status: COMPLETED ·Phase: PHASE2

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862 ·Status: COMPLETED ·Phase: PHASE4

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

NCT07301034 ·Status: RECRUITING ·Phase: PHASE3

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

NCT01136408 ·Status: COMPLETED ·Phase: PHASE2

Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy

NCT00352417 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

NCT02378064 ·Status: COMPLETED ·Phase: PHASE4

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

NCT00703482 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

NCT05856487 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

NCT03950843 ·Status: UNKNOWN ·Phase: PHASE3

A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction

NCT00215124 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease

NCT03718559 ·Status: COMPLETED ·Phase: PHASE4

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

NCT00617123 ·Status: COMPLETED ·Phase: PHASE3

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention

NCT01599078 ·Status: UNKNOWN ·Phase: NA

PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS)

NCT06239415 ·Status: RECRUITING

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

NCT05537571 ·Status: COMPLETED ·Phase: PHASE2

Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes

NCT01419418 ·Status: COMPLETED

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

NCT00307307 ·Status: COMPLETED ·Phase: PHASE4

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran

NCT02331602 ·Status: UNKNOWN ·Phase: PHASE4

Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes

NCT01852214 ·Status: COMPLETED ·Phase: NA

Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2

Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

NCT02140801 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State

NCT03086356 ·Status: COMPLETED ·Phase: PHASE1

Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody

NCT04141579 ·Status: COMPLETED ·Phase: NA